Medtronic (MDT) Tops Q1 EPS by 6c, Offers Guidance
Medtronic (NYSE: MDT) reported Q1 EPS of $1.17, $0.06 better than the analyst estimate of $1.11. Revenue for the quarter came in at $7.4 billion versus the consensus estimate of $7.24 billion.
GUIDANCE:
Medtronic sees FY2019 EPS of $5.10-$5.15, versus the consensus of $5.12.
- For fiscal year 2019, the company is increasing its organic revenue growth guidance from a range of 4.0 to 4.5 percent to a range of 4.5 to 5.0 percent. If recent exchange rates hold for the remainder of the fiscal year, the company's fiscal year 2019 revenue would be negatively affected by approximately $420 million to $520 million.
For earnings history and earnings-related data on Medtronic (MDT) click here.